No Data
No Data
No Data
No Data
No Data
Institutional Investors in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) See US$68m Decrease in Market Cap Last Week, Although Long-term Gains Have Benefitted Them.
Key Insights Institutions' substantial holdings in Longboard Pharmaceuticals implies that they have significant influence over the company's share price 50% of the business is held by the top 8 shar
Simply Wall StApr 20 09:08 ET
Express News | HC Wainwright & Co. Reiterates Buy on Longboard Pharmaceuticals, Maintains $60 Price Target
Moomoo 24/7Apr 16 10:34 ET
Analysts Offer Insights on Healthcare Companies: Verastem (VSTM), Laboratory (LH) and Longboard Pharmaceuticals (LBPH)
TipRanksApr 16 06:00 ET
Longboard Pharmaceuticals to Reveal Bexicaserin Study Results
TipRanksApr 15 09:32 ET
Express News | Cantor Fitzgerald Reiterates Overweight on Longboard Pharmaceuticals, Maintains $60 Price Target
Moomoo 24/7Apr 10 09:42 ET
Longboard Pharmaceuticals to Present Late-Breaking Data From the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15
PACIFIC Study Phase 1b/2a clinical data to be featured in a podium presentation at an Emerging Science Session at the AAN Annual Meeting Data will be featured in an encore presentation at the Sevent
BusinesswireApr 3 09:00 ET
No Data
No Data
Raza Zaidi : Any chances of recovery?
JOKER555OP Raza Zaidi: 30%